![](/img/cover-not-exists.png)
464P Apatinib (YN968D1) in performance status 2 or 3 patients with EGFR wild-type metastatic non-small cell lung cancer (NSCLC): A single-arm phase II study
Ya, Z.C.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.028
Date:
December, 2016
File:
PDF, 42 KB
english, 2016